[Updated on July 12] Integration of CiNii Articles into CiNii Research from April 1, 2022

Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.

Bibliographic Information

Title
Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.
Author
Yoshinori Ito, Koichi Nagasaki, Yoshio Miki, Takuj Iwase, Futoshi Akiyama, Masaaki Matsuura, Rie Horii, Masujiro Makita, Nahomi Tokudome, Masaru Ushijima, Masataka Yoshimoto, Shunji Takahashi, Tetsuo Noda, Kiyohiko Hatake.

Journal

Citations (0)

See more

References(0)

See more

Articles

See more

Research Data

See more

Books

See more

Dissertations

See more

Research Projects

See more

Products

See more

Details

  • CRID
    1010000782115821325
  • Article Type
    journal article
  • Data Source
    • KAKEN
Back to top